PLCG2 promotes hepatocyte proliferation in vitro via NF-κB and ERK pathway by targeting bcl2, myc and ccnd1-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PLCG2 promotes hepatocyte proliferation in vitro via NF-κB and ERK pathway by targeting bcl2, myc and ccnd1

Published:2019-09-24 Issue:1 Volume:47 Page:3786-3792
ISSN:2169-1401
Container-title:Artificial Cells, Nanomedicine, and Biotechnology
language:en
Short-container-title:Artificial Cells, Nanomedicine, and Biotechnology

Author:

Ma Donghui¹,Lian Fang²,Wang Xiaobai¹

Affiliation:

1. Department of Interventional Radiology and Vascular Surgery, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China;

2. Department of Clinical Laboratory, The Second Affiliated Hospital of Hainan Medical University, Haikou, Hainan, China

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Biomedical Engineering,General Medicine,Medicine (miscellaneous),Biotechnology

Link

https://www.tandfonline.com/doi/pdf/10.1080/21691401.2019.1669616

Reference44 articles.

1. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors

2. Significance of PIP2 hydrolysis and regulation of phospholipase C isozymes

3. Regulation of Phosphoinositide-specific Phospholipase C Isozymes

4. Structural views of phosphoinositide-specific phospholipase C: signalling the way ahead

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3 regulates M6A methylation-modified EBV-pri-miR-BART3-3p to promote NK/T cell lymphoma growth;Cancer Letters;2024-08

2. Biomarker potential of competing endogenous RNA networks in Polycystic Ovary Syndrome (PCOS);Non-coding RNA Research;2024-06

3. Insights into the effect of benzotriazoles in liver using integrated metabolomic and transcriptomic analysis;Environment International;2024-05

4. Unraveling the heterogeneity of cholangiocarcinoma and identifying biomarkers and therapeutic strategies with single-cell sequencing technology;Biomedicine & Pharmacotherapy;2023-06

5. Aggressive progression to EGFR tyrosine kinase inhibitors in advanced NSCLC patients: concomitant mutations, prognostic indicator and subsequent management;Journal of Cancer Research and Clinical Oncology;2023-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3